fda approval tirzepatide The New FDA-Approved Game Changer in Weight Management FDA Approves Mounjaro (tirzepatide) Injection

Why it matters: Farxiga increases glucose excretion, which creates an osmotic pull that increases urine output

Kevin Jones, MD Board Certified in Obesity Medicine Flow Wellness GLP-1 Support in California, Oregon, and Washington At Flow Wellness, we help patients understand every aspect of their GLP-1 treatment program, including medication dosing, side effect management, nutrition, and long-term success strategies

Adjustments are made after a two-week period based on response and tolerance

Vomiting, constipation, diarrhea, and abdominal discomfort round out the top digestive complaints, each occurring in 5% to 20% of users depending on dose escalation speed

This comes at a time when it has become part of our daily routines to take precautionary measures against Covid-19, as well as any other viruses that may be looming around us

2014 Feb;99(2):408-22